Seafood is a critical pillar of our global food chain, but aquaculture is a tough business, often plagued by high risks and low profits. The industry is in need of high-tech tools that make the job of farming the seafood we all want to eat easier and more profitable.
Oliver Tao was in elementary school in China when he first started trying to take apart computers and hack online games. Now, he uses his love of computers and his skills in pharmaceutical science to help drug companies design new medicines.
Winston Frazer learned it is not uncommon for soldiers and cops to remove their body armor, or simply not wear it regularly, because it is uncomfortable and unwieldy. It's a problem he thought his company’s 3D printing technology could help solve.
Microfibers that are shed from textiles are usually too small to see with the naked eye. But they end up contaminating everything from the fish we eat to the air we breathe.
What if the uniforms worn by American soldiers could prevent them from getting badly injured by a fire, or from getting bitten by bugs that may carry disease? That kind of question drives Keturah Postell in her work, each day.
Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Samuel Lahasky, PhD – a chemist with significant research and corporate product management experience – as Manager, Research Planning.
Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments
Early Charm Venture's portfolio company, SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has co-led a study focusing on improving respiratory treatments via SilcsBio’s Site Identification by Ligand Competitive Saturation (SILCS) technology.